Generation and multi-dimensional profiling of a childhood cancer cell line atlas defines new therapeutic opportunities
Claire Sun(Hudson Institute of Medical Research), Chris Jones(North Carolina State University), Caroline Drinkwater(Monash University), Dhanya Sooraj(Royal Perth Hospital), Maria Vinci(Cancer Research UK), Amos Hong Pheng Loh(KK Women's and Children's Hospital), Paul Daniel(Brigham and Women's Hospital), Maria Tsoli(Cancer Institute of New South Wales), Matthew D. Dun(Hunter Medical Research Institute), Motahhareh Tourchi(Hudson Institute of Medical Research), Michelle Monje(Howard Hughes Medical Institute), Louise Ludlow(Murdoch Children's Research Institute), Brett W. Stringer(Flinders University), E. Alejandro Sweet‐Cordero(University of California, San Francisco), Duncan E. Crombie(Monash University), Biljana Dumevska(UNSW Sydney), Dilru Habarakada(Monash University), David S. Ziegler(Cancer Institute of New South Wales), Sharon Y. Y. Low(National Neuroscience Institute), Eric H. Raabe(Johns Hopkins University), Nicole J. Chew(Australian Regenerative Medicine Institute), Phillip B. Storm(Children's Hospital of Philadelphia), Jeffrey Rubens(Johns Hopkins University), Melissa Loi(Monash University), Leanne C. Sayles(University of California, San Francisco), Naama Neeman(Hudson Institute of Medical Research), Wai Chin Chong(Hudson Institute of Medical Research), Hui Shi(Hudson Institute of Medical Research), Nataliya Zhukova, Vanessa Tyrrell(UNSW Sydney), Vanessa Tsui(Hudson Institute of Medical Research), Valérie Baubet(Children's Hospital of Philadelphia), Diana Carvalho(Institute of Cancer Research), Monty Panday(Monash University), Mateusz Koptyra(Children's Hospital of Philadelphia), Nur Farhana Syed Sulaiman(KK Women's and Children's Hospital), Gabrielle Bradshaw(Hudson Institute of Medical Research), Bryan W. Day(Queensland University of Technology), Adam Resnick(Children's Hospital of Philadelphia), Jamie I. Fletcher(Cancer Institute of New South Wales), Paul G. Ekert(Royal Children's Hospital), Sarah Parackal(Monash University), Shazia Adjumain(Hudson Institute of Medical Research), Dasun Fernando(Monash University), Elisabet Fernandez(Institute of Cancer Research), Yuqing Liang(Monash University), Anh Doan(Monash University), Mia Pörksen(Hudson Institute of Medical Research), Thy Nguyen(The University of Texas Health Science Center at Houston), Christie Sun(Hudson Institute of Medical Research)
Cited by 69
Related Papers
Advances in establishment and analysis of three-dimensional tumor spheroid-based functional assays for target validation and drug evaluation
|BMC Biology|2012|1k
Immune Checkpoint Inhibition for Hypermutant Glioblastoma Multiforme Resulting From Germline Biallelic Mismatch Repair Deficiency
|Journal of Clinical Oncology|2016|867
Analysis and Visualization of Longitudinal Genomic and Clinical Data from the AACR Project GENIE Biopharma Collaborative in cBioPortal
|Cancer Research|2023|847
Comprehensive Analysis of Hypermutation in Human Cancer
|Cell|2017|795